window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 15, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Women in Pharma

Women in PharmaDebbie2026-02-23T12:09:55+00:00
  • Clinical Development,Clinical Trials,Healthcare leadership,Oncology

    START appoints Salwan Al Mutar to lead clinical research in Dallas-Fort Worth

    START has appointed Salwan Al Mutar as director of clinical [...]

    read more
  • Artificial Intelligence,Biotech,Drug Development,Drug discovery,Research & Development

    ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board

    ProQR Therapeutics has entered a collaboration with Ginkgo Bioworks to [...]

    read more
  • Weite Oldenziel
    CDMOs & Manufacturing,Supply Chain & Logistics

    Ofichem unifies CDMO and pharmaceutical supply brands under single identity

    Ofichem has consolidated its multiple business units into a single [...]

    read more
  • Artificial Intelligence,Drug discovery,Funding,Technology and platforms

    DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development

    DeepCyte, a techbio company developing AI-driven toxicology tools for drug [...]

    read more
  • Artificial Intelligence,Drug Development,Drug discovery,Research & Development,Technology and platforms

    William Blair highlights Carterra as key player in AI-driven drug discovery shift

    A new analyst report from William Blair has highlighted Carterra [...]

    read more
  • Artificial Intelligence,Clinical Development,Genomics and sequencing,Obesity,Precision medicine,Technology and platforms

    23andMe study links genetics to GLP-1 weight loss outcomes and side effects

    This Nature-published study from the 23andMe Research Institute identifies genetic [...]

    read more
  • Clinical Trials,Funding,Opthalmology,Pharmaceuticals and therapeutics,Research & Development

    Life Biosciences raises $80M to advance gene therapy for optic neuropathies

    Life Biosciences has raised $80m in a Series D financing [...]

    read more
  • Biomanufacturing,Cell & Gene Therapy,Drug Development,Manufacturing,Partnerships & Funding

    Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration

    Scaling production of adeno-associated virus vectors remains a key barrier [...]

    read more
  • Clinical Development,Drug Development,Healthcare leadership,Movers & Shakers,Neurosciences,Oncology,Rare Diseases

    Allucent adds strategy leaders to expand therapeutic expertise

    Allucent has appointed new therapeutic strategy leaders across key disease [...]

    read more
  • Biotech,Funding,Genetic Diseases,Mergers & Acquisitions,Research & Development,RNA Therapeutics

    Circio raises NOK 250M in oversubscribed private placement to advance circRNA gene therapy platform

    Circio has raised NOK 250 million in a significantly oversubscribed [...]

    read more
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • William Blair highlights Carterra as key player in AI-driven drug discovery shift
    Categories: Artificial Intelligence, Drug Development, Drug discovery, Research & Development, Technology and platforms
  • 23andMe study links genetics to GLP-1 weight loss outcomes and side effects
    Categories: Artificial Intelligence, Clinical Development, Genomics and sequencing, Obesity, Precision medicine, Technology and platforms
  • Life Biosciences raises $80M to advance gene therapy for optic neuropathies
    Categories: Clinical Trials, Funding, Opthalmology, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top